Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein

Author:  ["Xiao Yan Zhou","Nobuyuki Shibusawa","Karuna Naik","Delia Porras","Karla Temple","Hesheng Ou","Kelly Kaihara","Michael W Roe","Matthew J Brady","Fredric E Wondisford"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Hepatic gluconeogenesis is essential for maintenance of normal blood glucose concentrations and is regulated by opposing stimulatory (cyclic adenosine monophosphate, cAMP) and inhibitory (insulin) signaling pathways1. The cAMP signaling pathway leads to phosphorylation of cAMP response element–binding (CREB) protein, resulting in recruitment of the coactivators CREB-binding protein (CBP) and p300 and subsequent activation of gluconeogenesis2,3,4,5. Insulin signaling leads to phosphorylation of CBP at serine 436, a residue near its CREB-interacting domain, but it is unknown whether this event modulates cAMP signaling6. Here, we show in vitro and in 'knock-in' mice that a mutant CBP (S436A) is aberrantly recruited to CREB protein, resulting in inappropriate activation of gluconeogenesis in the fed state and glucose intolerance resulting from increased hepatic glucose production. We propose that insulin signaling may directly regulate many cAMP signaling pathways at the transcriptional level by controlling CBP recruitment.

Cite this article

Zhou, X., Shibusawa, N., Naik, K. et al. Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nat Med 10, 633–637 (2004). https://doi.org/10.1038/nm1050

View full text

>> Full Text:   Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein

3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone

Suramin inhibits death receptor–induced apoptosis in vitro and fulminant apoptotic liver damage in m